DOCSLIB.ORG

Nanoscale Tuning of VCAM-1 Determines VLA-4–Dependent

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Nanoscale Tuning of VCAM-1 Determines VLA-4–Dependent Published OnlineFirst December 8, 2017; DOI: 10.1158/1541-7786.MCR-17-0272 Signal Transduction Molecular Cancer Research Nanoscale Tuning of VCAM-1 Determines VLA-4–Dependent Melanoma Cell Plasticity on RGD Motifs Katharina Amschler1, Eugen Kossmann1, Luise Erpenbeck1, Sebastian Kruss2, Tillmann Schill1, Margarete Schon€ 1, Sigrid M.C. Mockel€ 1, Joachim P. Spatz3, and Michael P. Schon€ 1 Abstract The biophysical fine-tuning of cancer cell plasticity is crucial for 1 in a dichotomic and density-dependent fashion. This was tumor progression but remains largely enigmatic. Although vas- accompanied by concordant regulation of F-actin cytoskeleton cular cell adhesion molecule-1 (VCAM-1/CD106) has been impli- remodeling, Rac1-expression, and paxillin-related adhesion for- cated in melanoma progression, here its presentation on endo- mation. The novel function of VCAM-1 was corroborated in vivo thelial cells was associated with diminished melanoma cell using two murine models of pulmonary metastasis. The regula- spreading. Using a specific nanoscale modulation of VCAM-1 tion of melanoma cell plasticity by VCAM-1 highlights the com- (tunable from 70 to 670 ligands/mm2) next to integrin ligands plex regulation of tumor–matrix interactions. (RGD motifs) in a bifunctional system, reciprocal regulation of integrin a4 (ITGA4/VLA-4/CD49d)-dependent adhesion and Implications: Nanotechnology has revealed a novel dichotomic spreading of melanoma cells was found. As the VCAM-1/VLA-4 function of the VCAM-1/VLA-4 interaction on melanoma cell receptor pair facilitated adhesion, while at the same time antag- plasticity, as nanoscale tuning of this interaction reciprocally onizing RGD-mediated spreading, melanoma cell morphogene- determines adhesion and spreading in a ligand density-depen- sis on these bifunctional matrices was directly regulated by VCAM- dent manner. Mol Cancer Res; 16(3); 528–42. Ó2017 AACR. Introduction progression and metastasis through binding to its predominant receptor, VLA-4 (very late antigen-4, a b integrin, CD29/CD49d) Notwithstanding recent advances in the treatment of melano- 4 1 on melanoma cells (11–14). Evidence for this notion came from ma, this aggressive skin tumor is fatal in most cases once distant both murine (12, 15) and human studies, with the latter linking metastases occur (1–5). The formation of metastases depends on VCAM-mediated interactions with expression of its ligand, VLA-4, extravasation of tumor cells from blood or lymph vessels, a and "aggressiveness" of the tumor cells (16). However, emerging complex process that is orchestrated by a plethora of accessory evidence suggests a more complex and versatile role of VCAM-1/ cells, soluble and sessile mediators as well as nanoscale adhesive VLA-4 interactions, at least in certain tumors (17), a notion that is interactions (6). supported by a recent study showing that strong upregulation of VCAM-1 (vascular cell adhesion molecule-1, CD106) was one VCAM-1 on pulmonary microvessels did not lead to increased of the first adhesion molecules implicated in metastasis-promot- experimental melanoma metastasis in vivo (18). ing endothelial cell interactions with malignant tumors, including A number of influencing factors have been implicated in the melanoma (7–10). Indeed, it has been a paradigm for 25 years focal regulation of VCAM-1 expression in vivo. These include now that endothelial expression of VCAM-1 facilitates melanoma shear stress on the vessel wall (19–22), tumor cell, and immune cell–produced cytokines and chemokines (23) as well as direct or indirect contact of tumor cells with the endothelial lining 1Department of Dermatology, Venereology and Allergology, University Medical (24–26). Under certain experimental conditions, melanoma cells Center, Gottingen,€ Germany. 2Department of Physical Chemistry, Georg August € 3 may stimulate expression of VCAM-1 directly at pulmonary University, Gottingen, Germany. Department of Cellular Biophysics, Max Planck fl Institute for Medical Research, Heidelberg and Laboratory of Biophysical metastatic sites (24). In addition to upregulation during in am- Chemistry, University of Heidelberg, Heidelberg, Germany. mation or metastasis, VCAM-1 can undergo ectodomain shedding leading to a net reduction of its density (27, 28). Note: Supplementary data for this article are available at Molecular Cancer Research Online (http://mcr.aacrjournals.org/). As density, clustering, or neighborhood relation of cell surface molecules can hardly be determined precisely on the nanoscale K. Amschler and E. Kossmann contributed equally to this article. under in vivo or conventional in vitro conditions, such as random Corresponding Author: Michael P. Schon,€ Department of Dermatology, coating of plastic tissue culture ware, the exact biophysical com- € € University Medical Center, Gottingen, Gottingen 37075, Germany. Phone: 49- position and consecutive functional relevance of VCAM-1- or 551-3966401; E-mail: [email protected] VLA-4–containing microdomains still remain unknown. Current- doi: 10.1158/1541-7786.MCR-17-0272 ly available model systems do not allow the study of isolated Ó2017 American Association for Cancer Research. VCAM-1 functions, let alone VCAM-1 functions in conjunction 528 Mol Cancer Res; 16(3) March 2018 Downloaded from mcr.aacrjournals.org on September 27, 2021. © 2018 American Association for Cancer Research. Published OnlineFirst December 8, 2017; DOI: 10.1158/1541-7786.MCR-17-0272 Nanoscale VCAM-1 and Melanoma Cell Plasticity with other adhesion receptors in bifunctional systems, with exact matrices with adherent cells were washed with PBS for 5 minutes. and measurable adjustment of biophysical properties. As a con- To ascertain the validity of the results with short adhesion periods, sequence of this less-than-optimal situation, the role of VCAM-1 the experiments were repeated with observation periods of up to 3 for the dynamics and morphogenesis of malignant cells cannot be hours. Phase-contrast images from random positions were taken understood. at different time points using an Axiovert 200 system (Zeiss). On the basis of nanopatterning and biofunctionalization con- cepts, we now provide experimental evidence for an unexpected Melanoma cell adhesion on endothelial cells dichotomic function of VCAM-1 toward human melanoma cells. Human umbilical vein endothelial cells (HUVEC; Lonza) were Experimental platforms modeling density variation of relevant cultured in endothelial cell growth medium (EGM; Lonza) sup- fi receptors and extracellular signals in a nanoscopically de ned plemented with gentamycin at 37 C and 5% CO2 in a humidified spatial arrangement allow the study of functional consequences of atmosphere. HUVECs were used at passages four to six. Upon important (patho)physiologic regulations, such as receptor dis- confluence, endothelial cells were exposed for 4 hours to recom- tribution. Therefore, such nanotechnological approaches can binant human TNFa (25 ng/mL; ImmunoTools). Binding sites of refine our models of tumor cell biology. To mimic the variable VCAM-1 were blocked for 1 hour using a function-blocking presentation of VCAM-1, we have generated mono- and bifunc- VCAM-1–directed antibody, or the cultures were exposed to an tional matrices based on gold nanopatterns functionalized with equal amount of an unrelated isotype-matched control antibody. VCAM-1 alone or interspersed with RGD-binding motifs, respec- PKH26 (Sigma)-labeled human melanoma cells (105) were tively. These nanoscopically defined matrices are models of endo- allowed to attach for 40 minutes. Wells were washed three times thelial cell surfaces in different states of activation. VCAM-1 site in a standardized manner with PBS. Adhesion and spreading were densities were tunable over one order of magnitude (from 70 documented using an inverted fluorescence microscope (Zeiss, ligand sites/mm2 to 670 ligand sites/mm2). We demonstrate that Axiovert 200) and quantitated using ImageJ (http://rsb.info.nih. nanoscopic VCAM-1 mediates firm attachment of melanoma cells gov/ij/). but, unexpectedly, simultaneously inhibits RGD-induced mela- noma cell spreading as well as the associated cytoskeletal reor- Nanopatterning ganization and focal contact formation in a density-dependent Nanostructured matrices were produced by block copolymer fashion. These results may shift the paradigm of a unidirectional micellar nanolithography (BCML; refs. 30–33). In short, glass function of VCAM-1 by demonstrating that its interaction with cover slides (24 Â 24, no. 1; Carl Roth) were cleaned in caroic acid VLA-4 can elicit a seemingly paradoxical inhibition of melanoma [1 hour, 1:3 H2O2 (30%): H2SO4 (p.A., Merck)]. These glass slides cell spreading. The inhibitory activity was specific for the VCAM-1/ were then sonicated four times for 5 minutes each and dried with VLA-4 interaction. Thus, our results indicate a new, density- N2. Micellar solutions were prepared in a Glove Box (Braun) by dependent function of VCAM-1 toward melanoma cells with dissolving the polystyrene-polyvinylpyridine-block-copolymers implications for the fine-tuning of integrin-mediated spreading. (Polysciences) in toluene (Merck). The micelles' cores were then loaded with HAuCl4 Á 3H2O (Sigma). The cleaned glass cover slips Materials and Methods were dip coated into the micelle solution in a standardized fashion. Organic parts of the micelles were removed by plasma Cell culture and preparation for functional experiments treatment (10% H2, 90% Argon, 0.4 mbar, 150 W, TePla 100; The
Load more

Recommended publications
  • BD Pharmingen™ PE Rat Anti-Human Integrin Β7
    BD Pharmingen™ Technical Data Sheet PE Rat Anti-Human Integrin β7 Product Information Material Number: 555945 Size: 100 tests Vol. per Test: 20 µl Clone: FIB504 Isotype: Rat (SD) IgG2a, κ Reactivity: QC Testing: Human Workshop: VI A024, VI 6T-101 Storage Buffer: Aqueous buffered solution containing BSA and ≤0.09% sodium azide. Description FIB504 reacts with mouse integrin β7 subunit (130 kD) but also cross reacts with human integrin β7. Integrin β7 associates with α4 (CD49d) expressed on subsets of lymphocytes and thymus. It also associates with αIEL (CD103) expressed on T cells adjacent to mucosal epithelium and intraepithelial lymphocytes. Integrin β7 plays an important role in the adhesion of leukocytes to endothelial cells promoting the transmigration of leukocytes to extravascular spaces during the inflammatory response. Profile of peripheral blood lymphocytes analyzed on a FACScan (BDIS, San Jose, CA) Preparation and Storage The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with R-PE under optimum conditions, and unconjugated antibody and free PE were removed by gel filtration chromatography. Store undiluted at 4° C and protected from prolonged exposure to light. Do not freeze. Application Notes Application Flow cytometry Routinely Tested Suggested Companion Products Catalog Number Name Size Clone 555844 PE Rat IgG2a, κ Isotype Control 100 tests R35-95 555945 Rev. 3 Page 1 of 2 Product Notices 1. This reagent has been pre-diluted for use at the recommended Volume per Test. We typically use 1 X 10e6 cells in a 100-µl experimental sample (a test). 2.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • CD Markers Are Routinely Used for the Immunophenotyping of Cells
    ptglab.com 1 CD MARKER ANTIBODIES www.ptglab.com Introduction The cluster of differentiation (abbreviated as CD) is a protocol used for the identification and investigation of cell surface molecules. So-called CD markers are routinely used for the immunophenotyping of cells. Despite this use, they are not limited to roles in the immune system and perform a variety of roles in cell differentiation, adhesion, migration, blood clotting, gamete fertilization, amino acid transport and apoptosis, among many others. As such, Proteintech’s mini catalog featuring its antibodies targeting CD markers is applicable to a wide range of research disciplines. PRODUCT FOCUS PECAM1 Platelet endothelial cell adhesion of blood vessels – making up a large portion molecule-1 (PECAM1), also known as cluster of its intracellular junctions. PECAM-1 is also CD Number of differentiation 31 (CD31), is a member of present on the surface of hematopoietic the immunoglobulin gene superfamily of cell cells and immune cells including platelets, CD31 adhesion molecules. It is highly expressed monocytes, neutrophils, natural killer cells, on the surface of the endothelium – the thin megakaryocytes and some types of T-cell. Catalog Number layer of endothelial cells lining the interior 11256-1-AP Type Rabbit Polyclonal Applications ELISA, FC, IF, IHC, IP, WB 16 Publications Immunohistochemical of paraffin-embedded Figure 1: Immunofluorescence staining human hepatocirrhosis using PECAM1, CD31 of PECAM1 (11256-1-AP), Alexa 488 goat antibody (11265-1-AP) at a dilution of 1:50 anti-rabbit (green), and smooth muscle KD/KO Validated (40x objective). alpha-actin (red), courtesy of Nicola Smart. PECAM1: Customer Testimonial Nicola Smart, a cardiovascular researcher “As you can see [the immunostaining] is and a group leader at the University of extremely clean and specific [and] displays Oxford, has said of the PECAM1 antibody strong intercellular junction expression, (11265-1-AP) that it “worked beautifully as expected for a cell adhesion molecule.” on every occasion I’ve tried it.” Proteintech thanks Dr.
    [Show full text]
  • Integrin Alpha 4 Recombinant Protein Cat
    Integrin alpha 4 Recombinant Protein Cat. No.: 95-110 SDS-PAGE analysis of recombinant Integrin alpha 4 fragment on Coomassie Blue-stained 4-20% gradient gel. Specifications SPECIES: Human SOURCE SPECIES: E. coli SEQUENCE: aa 131 - 275 FUSION TAG: Fusion Partner: N-terminal His-tag TESTED APPLICATIONS: ELISA, WB APPLICATIONS: This recombinant protein can be used for WB and ELISA. For research use only. PREDICTED MOLECULAR 17 kDa (Calculated) WEIGHT: Properties PURITY: ~95% PHYSICAL STATE: Liquid BUFFER: 50mM Tris pH7.5, 150mM NaCl, 5 mM MgCl2 Store in working aliquots at -70˚C. Avoid freeze/thaw cycles. When working with proteins STORAGE CONDITIONS: care should be taken to keep recombinant protein at a cool and stable temperature. September 24, 2021 1 https://www.prosci-inc.com/integrin-alpha-4-recombinant-protein-95-110.html Additional Info OFFICIAL SYMBOL: ITGA4 Integrin alpha 4 Antibody: IA4, CD49D, Integrin alpha-4, CD49 antigen-like family member ALTERNATE NAMES: D ACCESSION NO.: NP_000876 PROTEIN GI NO.: 67191027 GENE ID: 3676 Background and References The integrin alpha 4 (also known as CD49d and ITGA4) belongs to the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha and beta chains (reviewed in 1). Alpha 4 (4) chain associates with either beta 1 (1) or beta 77) chain. It has been demonstrated that the putative ligand-binding sites of both integrin 41 and 47 is located on the 4 chain. These ligands included Madcam, VCAM, and fibronectin (2-4). Madcam is known as the principal ligand for BACKGROUND: integrin a4b7.
    [Show full text]
  • Integrins As Therapeutic Targets: Successes and Cancers
    cancers Review Integrins as Therapeutic Targets: Successes and Cancers Sabine Raab-Westphal 1, John F. Marshall 2 and Simon L. Goodman 3,* 1 Translational In Vivo Pharmacology, Translational Innovation Platform Oncology, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany; [email protected] 2 Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK; [email protected] 3 Translational and Biomarkers Research, Translational Innovation Platform Oncology, Merck KGaA, 64293 Darmstadt, Germany * Correspondence: [email protected]; Tel.: +49-6155-831931 Academic Editor: Helen M. Sheldrake Received: 22 July 2017; Accepted: 14 August 2017; Published: 23 August 2017 Abstract: Integrins are transmembrane receptors that are central to the biology of many human pathologies. Classically mediating cell-extracellular matrix and cell-cell interaction, and with an emerging role as local activators of TGFβ, they influence cancer, fibrosis, thrombosis and inflammation. Their ligand binding and some regulatory sites are extracellular and sensitive to pharmacological intervention, as proven by the clinical success of seven drugs targeting them. The six drugs on the market in 2016 generated revenues of some US$3.5 billion, mainly from inhibitors of α4-series integrins. In this review we examine the current developments in integrin therapeutics, especially in cancer, and comment on the health economic implications of these developments. Keywords: integrin; therapy; clinical trial; efficacy; health care economics 1. Introduction Integrins are heterodimeric cell-surface adhesion molecules found on all nucleated cells. They integrate processes in the intracellular compartment with the extracellular environment. The 18 α- and 8 β-subunits form 24 different heterodimers each having functional and tissue specificity (reviewed in [1,2]).
    [Show full text]
  • Laser Irradiation Alters the Expression Profile of Genes Involved in the Extracellular Matrix in Vitro
    Hindawi Publishing Corporation International Journal of Photoenergy Volume 2014, Article ID 604518, 17 pages http://dx.doi.org/10.1155/2014/604518 Research Article Laser Irradiation Alters the Expression Profile of Genes Involved in the Extracellular Matrix In Vitro Sandra M. Ayuk, Nicolette N. Houreld, and Heidi Abrahamse Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein 2028, South Africa Correspondence should be addressed to Heidi Abrahamse; [email protected] Received 16 April 2014; Accepted 25 May 2014; Published 23 June 2014 Academic Editor: Gerhard Litscher Copyright © 2014 Sandra M. Ayuk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The extracellular matrix (ECM) forms the basis of every phase in wound healing. Healing may be impaired if some ofthese components are destroyed. Photobiostimulation has demonstrated a stimulatory response in biological processes. This study aimed to evaluate various genes involved in the ECM, in response to laser irradiation. Isolated human skin fibroblasts were used in 2 three different cell models, namely, normal, normal wounded, and diabetic wounded. Cells were irradiated with 5 J/cm using 2 a continuous wave diode laser emitting at a wavelength of 660 nm and incubated for 48 h. Nonirradiated (0 J/cm )normaland diabetic wounded cells served as the control. Real-time reverse transcription (RT) quantitative polymerase chain reaction (qPCR) was used to determine the expression of 84 genes in a PCR array. There was a significant upregulation of 29 genes in the normal cells, 32 genes in the normal wounded cells, and 18 genes in the diabetic wounded cells as well as a downregulation of 19 genes (normal), 6 genes (normal wounded), and 31 genes (diabetic wounded).
    [Show full text]
  • Fibroblasts from the Human Skin Dermo-Hypodermal Junction Are
    cells Article Fibroblasts from the Human Skin Dermo-Hypodermal Junction are Distinct from Dermal Papillary and Reticular Fibroblasts and from Mesenchymal Stem Cells and Exhibit a Specific Molecular Profile Related to Extracellular Matrix Organization and Modeling Valérie Haydont 1,*, Véronique Neiveyans 1, Philippe Perez 1, Élodie Busson 2, 2 1, 3,4,5,6, , Jean-Jacques Lataillade , Daniel Asselineau y and Nicolas O. Fortunel y * 1 Advanced Research, L’Oréal Research and Innovation, 93600 Aulnay-sous-Bois, France; [email protected] (V.N.); [email protected] (P.P.); [email protected] (D.A.) 2 Department of Medical and Surgical Assistance to the Armed Forces, French Forces Biomedical Research Institute (IRBA), 91223 CEDEX Brétigny sur Orge, France; [email protected] (É.B.); [email protected] (J.-J.L.) 3 Laboratoire de Génomique et Radiobiologie de la Kératinopoïèse, Institut de Biologie François Jacob, CEA/DRF/IRCM, 91000 Evry, France 4 INSERM U967, 92260 Fontenay-aux-Roses, France 5 Université Paris-Diderot, 75013 Paris 7, France 6 Université Paris-Saclay, 78140 Paris 11, France * Correspondence: [email protected] (V.H.); [email protected] (N.O.F.); Tel.: +33-1-48-68-96-00 (V.H.); +33-1-60-87-34-92 or +33-1-60-87-34-98 (N.O.F.) These authors contributed equally to the work. y Received: 15 December 2019; Accepted: 24 January 2020; Published: 5 February 2020 Abstract: Human skin dermis contains fibroblast subpopulations in which characterization is crucial due to their roles in extracellular matrix (ECM) biology.
    [Show full text]
  • CD103 / ITGAE Antibody
    FOR RESEARCH USE ONLY! 02/21 CD103 / ITGAE Antibody CATALOG NO.: A2300-50 (50 µg) A2300-100 (100 µg) BACKGROUND DESCRIPTION: ITGAE, also known as CD103, is an integrin that pairs with the beta 7 integrin to form the human mucosal lymphocyte-1 antigen. ITGAE is preferentially expressed in human intestinal intraepithelial lymphocytes (IEL). It has a role in adhesion and may serve as an accessory molecule for IEL activation. ITGAE has been associated with diseases such as hairy cell leukemia and splenic marginal zone lymphoma. The presence of cytotoxic T cells positive for CD103 expression has been linked to prolonged survival in several malignancies, including gastric cancer, and is currently being explored as a prognostic biomarker as well as a potential therapeutic target. ITGAE; Mucosal Lymphocyte 1 Antigen; HML-1 Antigen; Integrin Subunit Alpha E; HUMINAE ALTERNATE NAMES: ANTIBODY TYPE: Rabbit polyclonal HOST/ISOTYPE: Rabbit / IgG IMMUNOGEN: Human CD103 peptide sequence (amino acids 19 to 200) PURIFICATION: Affinity purification MOLECULAR WEIGHT: 130 kDa calculated; 110 kDa observed FORM: Liquid FORMULATION: In PBS with 0.02% sodium azide, 50% glycerol, pH 7.3 SPECIES REACTIVITY: Human, Mouse, Rat STORAGE CONDITIONS: Store at -20 °C. Avoid repeated freeze-thaw cycles APPLICATIONS: Western Blot (WB): 1:500 to 1:2000 dilution This information is only intended as a guide. The optimal dilutions must be determined by the user Western blot analysis of lysates prepared from various cell lines using CD103 antibody RELATED PRODUCTS: Anti-α4β7 Integrin (Vedolizumab), Humanized Antibody (Cat. No. A2140) Anti-Alpha 5 Beta 1 Integrin (Volociximab), Human IgG4 Antibody (Cat.
    [Show full text]
  • Active Detachment Involves Inhibition of Cell-Matrix Contacts of Malignant
    0023-6837/03/8311-1583$03.00/0 LABORATORY INVESTIGATION Vol. 83, No. 11, p. 1583, 2003 Copyright © 2003 by The United States and Canadian Academy of Pathology, Inc. Printed in U.S.A. Active Detachment Involves Inhibition of Cell-Matrix Contacts of Malignant Melanoma Cells by Secretion of Melanoma Inhibitory Activity Anja-Katrin Bosserhoff, Raphael Stoll, Jonathan P. Sleeman, Frauke Bataille, Reinhard Buettner, and Tad A. Holak Institute of Pathology (A-KB, FB), University of Regensburg, Regensburg, Institute of Pathology (RB), University of Bonn, Bonn, Institute of Toxicology and Genetics (JPS), Forschungszentrum Karlsruhe, Karlsruhe, Max Planck Institute of Biochemistry (TAH), Munich, and Faculty of Chemistry (RS), Ruhr-University Bochum, Bochum, Germany. SUMMARY: Melanoma inhibitory activity (MIA) has been identified as a small protein secreted from malignant melanoma cells. Recent results revealed a direct interaction of MIA and epitopes within extracellular matrix proteins including fibronectin. The aim of this study was to analyze functional consequences mediated by this interaction. Here we show that MIA interferes specifically with attachment of melanoma cells to fibronectin, a phenomenon we refer to as active detachment. Antibodies inhibiting binding of ␣4␤1 and ␣5␤1 integrins to fibronectin cross-react specifically with MIA, suggesting that MIA shares significant structural homology with the binding pockets of these integrins and thereby masks the respective epitopes on extracellular matrix molecules. Several peptides derived from fibronectin and from a phage display screening were tested with respect to a potential MIA-inhibitory effect. In vitro tests identified two peptides affecting MIA function; both inhibited growth of melanoma metastases in vivo.
    [Show full text]
  • Integrin-Alpha 4 / Cd49d (CT) Antibody
    21.10.2014Integrin-alpha 4 / CD49d (CT) antibody Rabbit Anti-Human/Mouse/Rat Integrin-alpha 4 (CD49d, ITGA4, IA4; CT) Instruction Manual Catalog Number PK-AB718-4783 Synonyms Integrin alpha 4 Antibody: CD49d, ITGA4, IA4, alpha 4 subunit of VLA-4 receptor Description The Integrin-alpha 4 (also known as CD49d and ITGA4) belongs to the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha and beta chains. Alpha 4 chain associates with either beta 1 or beta 7 chain. It has been demonstrated that the putative ligand-binding sites of both Integrin-alpha 4 beta 1 and alpha 4 beta 7 is located on the alpha 4 chain. These ligands included Madcam, VCAM, and fibronectin. Madcam is known as the principal ligand for integrin alpha 4 beta 7. Recently it was also demonstrated that HIV-1 envelope can mimic Madcam by binding to and signaling though Integrin-alpha 4 beta 7, the gut mucosal homing receptor for peripheral T cells. Despite its predicted molecular weight, Integrin alpha 4 will often run at higher molecular weight in SDS-PAGE. At least two isoforms are known to exist. The immunogen to this antibody is outside of the Integrin-alpha 4 recombinant protein fragment and thus will not recognize it. Quantity 100 µg Source / Host Rabbit Immunogen Integrin-alpha 4 antibody was raised against a 13 amino acid peptide from near the carboxy terminus of human Integrin-alpha 4. Purification Method Affinity chromatography purified via peptide column. Clone / IgG Subtype Polyclonal antibody Species Reactivity Human, Mouse, Rat Specificity At least two isoforms are known to exist.
    [Show full text]
  • Transcriptome-Wide Analysis of CXCR5 Deficient Retinal Pigment
    Article Transcriptome‐wide analysis of CXCR5 deficient retinal pigment epithelial (RPE) cells reveals molecular signature of RPE homeostasis Supplementary data Madhu Sudhana Saddala 1, Anton Lennikov 1, Anthony Mukwaya 2, and Hu Huang 1,* 1 Department of Ophthalmology, University of Missouri, Columbia, MO 65212, United States of America; [email protected] (M.S.S.); [email protected] (A.L.) 2 Department of Ophthalmology, Institute for Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, 58183 , Sweden; [email protected] * Correspondence: [email protected]; Tel: +1 573‐882‐9899 # Madhu Sudhana Saddala and Anton Lennikov have contributed equally to this work. Keywords: Age‐related macular degeneration; CXCR5; EMT, FoxO; Mitochondria; RNA‐Seq, Gene Ontology; KEGG; Retinal pigment epithelium Supplementary Figures Biomedicines 2020, 8, x; doi: FOR PEER REVIEW www.mdpi.com/journal/biomedicines Biomolecules 2020, 10, x FOR PEER REVIEW 2 of 13 Biomolecules 2020, 10, x FOR PEER REVIEW 3 of 13 Figure S1: Quantitative profiling of mouse RPE tissue between control and CXCR5 ko groups. Pearson correlation coefficient plot of the log2 ratio between two groups (A) before and (B) after normalization. Potential relationships or correlations amongst the different data attributes is to leverage a pair‐wise correlation matrix in control and CXCR5 knockout groups. Biomolecules 2020, 10, x FOR PEER REVIEW 4 of 13 Biomolecules 2020, 10, x FOR PEER REVIEW 5 of 13 Figure S2: Potential relationships or correlations amongst the different data attributes is to leverage a pair‐wise correlation matrix in control and CXCR5 knockout groups. (A) heatmap of total differentially expressed genes (B) The cluster of main heatmap represented twenty differentially expressed genes.
    [Show full text]
  • Integrin Alpha 4 Recombinant Protein Cat
    Integrin alpha 4 Recombinant Protein Cat. No.: 95-110 SDS-PAGE analysis of recombinant Integrin alpha 4 fragment on Coomassie Blue-stained 4-20% gradient gel. Specifications SPECIES: Human SOURCE SPECIES: E. coli SEQUENCE: aa 131 - 275 FUSION TAG: Fusion Partner: N-terminal His-tag TESTED APPLICATIONS: ELISA, WB APPLICATIONS: This recombinant protein can be used for WB and ELISA. For research use only. PREDICTED MOLECULAR 17 kDa (Calculated) WEIGHT: Properties PURITY: ~95% PHYSICAL STATE: Liquid BUFFER: 50mM Tris pH7.5, 150mM NaCl, 5 mM MgCl2 Store in working aliquots at -70˚C. Avoid freeze/thaw cycles. When working with proteins STORAGE CONDITIONS: care should be taken to keep recombinant protein at a cool and stable temperature. October 2, 2021 1 https://www.prosci-inc.com/integrin-alpha-4-recombinant-protein-95-110.html Additional Info OFFICIAL SYMBOL: ITGA4 Integrin alpha 4 Antibody: IA4, CD49D, Integrin alpha-4, CD49 antigen-like family member ALTERNATE NAMES: D ACCESSION NO.: NP_000876 PROTEIN GI NO.: 67191027 GENE ID: 3676 Background and References The integrin alpha 4 (also known as CD49d and ITGA4) belongs to the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha and beta chains (reviewed in 1). Alpha 4 (4) chain associates with either beta 1 (1) or beta 77) chain. It has been demonstrated that the putative ligand-binding sites of both integrin 41 and 47 is located on the 4 chain. These ligands included Madcam, VCAM, and fibronectin (2-4). Madcam is known as the principal ligand for BACKGROUND: integrin a4b7.
    [Show full text]